As a result, the bispecific fusion protein 17V05 effectively inhibited multiple proinflammatory cytokines and chemokines, including IL-6, IL-8, CXCL1, and MCP-1, which are all involved in the development of AMD [17]. The gene discussed is CCL2; the disease is age-related macular degeneration.